Skip to content Print

Actim Partus - Strong scientific proof of reliability

Everything we claim about Actim Partus test, we can also prove!

Publications:

  • NEW! Cooper S et al. Diagnostic accuracy of rapid phIGFBP-1 assay for predicting preterm labor in symptomatic patients. Journal of Perinatology (2011) 1-6.

  • NEW! Danti L et al. The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. J Matern Fetal Neonatal Med. (2011) 24:1262-1266.
  • NEW! Dögl M, Skogvoll E, Heimstad R. Cervical insulin-like growth factor binding protein-1 (IGFBP-1) to predict spontaneous onset of labor and induction to delivery interval in post-term pregnancy.
    Acta Obstet Gynecol Scand. (2011) 90:57-62.
  • NEW! Rahkonen L. Prediction of pre-term delivery with phosphorylated insulin-like growth factor-binding protein-1.
    European Obstetrics & Gynecology (2011) 6:3-7.
  • NEW! Riboni F et al. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin.
    Arch Gynecol Obstet. (2011) Jan 28. Epub ahead of print.
  • NEW! Riboni F et al. Combination of biochemical markers in predicting pre-term delivery.
    Arch Gynecol Obstat (2011) May 03. Epub ahead of print.
  • Adeyemi O, Osoba L. The role of phosphorylated insulin-like growth factor binding protein-1 in predicting pre-term labour in twin pregnancies. Journal of Obstetrics and Gynaecology (2010) 30:571-573.
  • Brik Spinelli M et al. Phosphorylated insulin-like growth factor binding protein-1 and cervical measurement in women with threatening preterm birth. Acta Obstet Gynecol Scand (2010) 89:268-74.
  • Nor Azlin MI et al. Role of phIGFBP-1 and ultrasound cervical length in predicting pre-term labour.
    Journal of Obstetrics and Gynaecology (2010) 30:456-460.
  • Tanir HM, Sener T, Yildiz Z. Cervical phosphorylated insulin-like growth factor binding protein-1 for the prediction of preterm delivery in symptomatic cases with intact membranes. J Obstet Gynaecol Res (2009) 1:66-72.
  • Altinkaya O et al. Cervical phosphorylated insulin-like growth factor binding protein-1 in prediction of preterm delivery. Arch Gynecol Obstet (2009) 279:279-283. Epub 2008 Jun 13.
  • Balic D, Latifagic A, Hudic I. Insulin-like growth factor-binding protein-1 (IGFBP-1) in cervical secretions as a predictor of preterm delivery. J Matern Fetal Neonatal Med (2008) 21:297-300.
  • Bittar R et al. Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulin-like growth factor-binding protein-1.
    Ultrasound Obstet Gynecol (2007) 29:562-567.
  • Eroglu D et al. Prediction of preterm delivery among women with threatened preterm labor.
    Gynecol Obstet Invest (2007) 64:109-116.
  • Paternoster DM et al. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery.
    Acta Obstet Gynecol Scand (2007) 86:151-155.
  • Ting HS et al. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore (2007) 36:399-402.
  • Elizur SE et al. Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test. Am J Perinatol (2005) 22:305-309.
  • Akercan F et al. Value of cervical phosphorylated insulinlike growth factor binding protein-1 in the prediction of preterm labor. J Reprod Med (2004) 49:368-372.
  • Kwek K et al. Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour. Ann Acad Med Singapore (2004) 33:780-783.
  • Park O-R et al. Usefulness of phosphorylated insulin-like growth factor binding protein-1 for prediction of preterm delivery. Korean J Obstet Gynecol (2003) 46:1378-1383. (In Korean, abstract in English).
  • Lembet A et al. New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions. Acta Obstet Gynecol Scand (2002) 81:706-712.
  • Kekki M et al. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand (2001) 80:546-551.
  • Shine BK et al. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Korean J Obstet Gynecol (2001) 44:2250-2256. (In Korean, abstract in English).
  • Kekki M et al. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet (1999) 353:1494.
  • Nuutila M et al. Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness. Obstet Gynecol (1999) 94:243-249.

Abstracts and Posters:

  • Sanchez Martinez M et al. Comparison of ecographic cervical length at two different cut-off points and two biochemical markers as predictors of spontaneous preterm delivery in women admitted because of preterm labor. Ultrasound Obstet Gynecol (2006) 28:583-584. Poster abstract in 16th World Congress on Ultrasound in Obstetrics and Gynecology, Sept. 3-7, 2006, London, UK.
  • Turnell R et al. A direct comparison of fetal fibronectin [FFN®] and pIGFBP-1 [actim™ Partus] in the diagnosis of preterm labour [PTL]. Abstract in JOGC  (2005), 17:O-OBS-014.
  • Bittar R et al. Cervical insulin like growth factor binding protein-1 (phIGFBP-1) in patients at increased risk for preterm delivery: preliminary results. Poster presented in 5th World Congress of Perinatal Medicine, Sept. 23-27, 2001, Barcelona, Spain.

Reviews:

  • Rutanen E-M. Insulin-like growth factors in obstetrics. Opin Obstet Gynecol (2000) 12:163-168. 


Back to top